What to Expect From a Full-Body MRI | Prenuvo Scan Walkthrough

Greenfield believes the common medical path of surgery or stem cell injections for back arthritis is often unnecessary. He points to his own severe MRI findings and contrasts his pain‑free daily function with the radical options others push. His approach is built on the idea that the body can compensate for structural degeneration if the surrounding musculature is robust and posture is controlled. He highlights that many people with similar findings end up in surgery largely because they don’t do this deep stabilisation work and instead rely on passive treatments. The MRI here simply reinforces that his exercise program is working and should continue.

Greenfield briefly mentions that he is asymptomatic despite the MRI showing a protruding or bulging abnormality at C5‑C6. He sees this finding as validation that his existing neck exercises are working, rather than as a sign to escalate care. The segment is short, but it reinforces his pattern of using scans as feedback for a routine, not as a trigger for alarm.

Greenfield admits his knees are damaged after two decades of Ironman, Spartan races, and adventure racing. The MRI confirms degenerative changes and a small meniscal tear with effusion. Five years ago his left knee was at 30 % capacity; after adopting the Knees Over Toes protocol, he reports an 85 % subjective improvement and minimal daily pain. He still avoids activities that demand deep flexion under load, such as heavy squats or sprinting on uneven terrain. He would consider future cartilage‑repair technologies only if they become reliable, but for now he manages entirely with exercise. His story underscores that even a structurally compromised joint can be functional with the right strength routine.

Greenfield briefly covers that his MRI shows bilateral hip bursitis yet he has no pain. He uses the same logic as with his spine and knees: the finding only reinforces his commitment to his existing hip‑opener routine, rather than prompting new interventions. He acknowledges he will seek a professional opinion to ensure nothing else is developing, but the absence of symptoms again grounds his approach.

Greenfield points to his liver hemangioma (11 mm) that has stayed stable for five years and was confirmed benign by a dedicated liver MRI and fibroscan. He plans to repeat the full‑body MRI every few years to track such findings. This turns the scan from a one‑time anomaly hunt into a structured surveillance tool. He is careful to frame this as a personal protocol suited to his risk tolerance and resources, not a public‑health recommendation.

Greenfield explains that because he is asymptomatic and has a network of trusted specialists, he can look at findings like a pontine hyperintensity or spine degeneration without jumping to invasive procedures. He sees the scan as a way to monitor benign lesions over time (e.g., a stable liver hemangioma he has tracked for 5 years) and to motivate consistent preventive habits. The expense and stress are real downsides, but for someone dedicated to self‑experimentation and armed with a reasonable lens, the scan offers actionable insights that regular check‑ups miss.

He illustrates this with his own spine, brain, liver, sinuses, hips, and knees—all showing abnormalities on MRI, yet he remains pain‑free and high‑functioning. The pontine hyperintensity in his brain is flagged, but he has no headaches, brain fog, or neurological symptoms, so he only plans a SPECT scan out of curiosity, not alarm. The liver hemangioma (11 mm) has not grown in five years and a previous fibroscan called his liver 'like a newborn baby's'. He wants viewers to understand that a finding is just one data point; the body's function and lack of symptoms should guide intervention.